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Abstract: Over the last three decades, protein engineering has established itself as an 
important tool for the development of enzymes and (therapeutic) proteins with improved 
characteristics. New mutagenesis techniques and computational design tools have greatly 
aided in the advancement of protein engineering. Yet, one of the pivotal components to 
further advance protein engineering strategies is the high-throughput screening of variants. 
Compartmentalization is one of the key features allowing miniaturization and acceleration 
of screening. This review focuses on novel screening technologies applied in protein 
engineering, highlighting flow cytometry- and microfluidics-based platforms. 
Keywords: high-throughput screening; FACS-based screening platforms; microfluidics-based 
screening platforms; protein engineering; in vitro compartmentalization 
 
1. Introduction 
Nature offers many different biocatalysts and (therapeutic) proteins, which usually require 
alterations in order to meet criteria with regard to reaction conditions and usage under industrial or 
medical circumstances. Protein engineering techniques can aid in the evolution of properties such as 
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activity, stability, expression, selectivity and inhibition [1,2]. In the last few decades, much progress 
has been made in this field due to advances in mutagenesis including directed evolution, semi-rational 
approaches and computational methods. Nowadays, structural and mechanistic knowledge of the 
protein of interest as well as bioinformatics tools are applied in the prediction of hot spots [2]; 
consequently, small focused libraries are created which can be screened in a short time [3]. Thus, 
significant improvements in protein characteristics can be achieved. However, finding the best 
approach to generate a mutant library is only the starting point in the roadmap to a molecule with the 
optimally desired characteristics [4]. The choice of a suitable screening or selection system is one of 
the most important checkpoints in the design of an experiment [4,5]. In general, selection strategies are 
less labor-intensive and more efficient than screening techniques: whole libraries of variants can be 
analyzed simultaneously. Thus, the size of the library—usually 1010–1013 variants—is not a limiting 
factor. In screening strategies, each variant’s activity is determined individually; the size of the library 
is therefore usually much smaller, though the use of robotics has made the screening process less 
labor-intensive [6]. Despite the clear difference in concept and in library size that can be tested, the 
words screening and selection appear to be interchangeable in current literature. 
The choice for a screening strategy is dictated by some constraints: a reliable production host and  
its transformation efficiency, assay development (compounds selection, detection limits) and the 
availability of analytical tools and standardized equipment [4]. All currently available strategies, such as 
agar plate screens, microtiter plate screens, cell surface display selections or screens of single (bacterial) 
cells functioning as microreactors, have their advantages and disadvantages [7]. In search for a higher 
throughput, compartmentalization techniques have emerged. Inspired by nature where reactions are 
taking place within cells or organelles, water-in-oil droplets of the size of Escherichia coli bacteria 
have been developed. These cell-like chambers brought some new advantages to screening, one of the 
main benefits being the miniaturization of the reaction volume to a few microliters. As a consequence, 
a higher throughput can be achieved, which means screening a higher number of variants in a shorter 
amount of time [8,9]. However, reducing reaction volumes has some limitations: the reduction is 
associated with physical restrictions in terms of evaporation and capillarity [10]. Thus, a further 
decrease in reaction volume was impossible until the introduction of microfluidics technology, which 
enabled the decrease of the reaction volume down to a few picoliters [9,11]. 
Two techniques have emerged in the field of protein engineering together with the development of 
compartments: fluorescence-activated cell sorting (FACS) and microfluidics. This review focuses on 
advances in the application of these methods in the context of protein engineering, with an emphasis 
on applications in enzyme engineering. Chosen for their novelty and general applicability, recent 
examples from the last five years are described here to illustrate the use of high-throughput screening 
technologies; these examples are summarized in Tables 1 and 2. 
2. Nature’s Own Compartments in FACS-Based Screening Platforms 
A prerequisite of any screening or selection method is a physical link between the genotype and the 
resulting phenotype [5]; this is typically a ‘compartment’, such as prokaryotic or eukaryotic cells. 
Thus, the impact of the change in the nucleic acid sequence can be observed and characterized at the 
level of the expression product, the protein [8]. Several screening and selection strategies based on 
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nature’s own compartments have been developed, e.g., mammalian cell display, yeast surface display 
and cell-based screening; these have been combined with FACS to achieve a higher throughput of 
screening [6,7]. Evolution of the protein of interest must lead to a fluorescent signal for sorting. 
Fluorescent (non-)natural probes are commercially available, although natural substrates should 
preferably be used to prevent false positive results: e.g., the protein of interest could strongly  
bind to the non-natural fluorescent probe or not show any improvement in activity towards its natural 
substrate [12]. 
2.1. Display of Protein Variants on Eukaryotic Cells 
Antibody display systems using phages, yeast cells or ribosomes have seen many successes in  
the development of new therapeutics. However, only small antibody fragments can be displayed; 
reformatting of these fragments into soluble, full-length IgGs is not always an easy task. In addition,  
the selected antibody fragments may possess either different posttranslational modifications or none at  
all [13–15]. To isolate and affinity mature antibodies, several mammalian display methods have been 
developed, which usually rely on transient transfection of mammalian cells, resulting in rapid protein 
expression. Episomal vectors can be stably transfected at high efficiency and maintained at low  
copy number; hence, multiple rounds of selection are now possible [16]. Bowers et al. describe a 
generalized approach that imitates the adaptive immune system by coupling in vitro somatic 
hypermutation (SHM) with mammalian cell display [14]. In the adaptive immune system, SHM is used 
to mature antibodies and generate high-affinity antibody responses through the enzymatic activity of 
activation-induced cytidine deaminase (AID). This enzyme targets DNA encoding the immunoglobulin 
variable domains, and preferentially deaminates cytidine residues at hotspot motifs [17,18]. 
In non-B cells, SHM can be achieved by expression of recombinant AID. HEK293 cells were stably 
transfected with episomal vectors expressing a library based on germline V-gene segments with 
recombined human regions. A C-terminal transmembrane domain was added to the full-length IgG1 
heavy chain (HC) to anchor the antibody on the cell surface. Antibodies were selected in two rounds 
against the target antigen human β-neuronal growth factor (hβNGF). After sequencing analysis,  
six unique clones were chosen for affinity maturation via SHM. Then, an additional three rounds of 
sorting were performed with increasing stringency, and the best hβNGF-binding antibody-expressing 
cells were selected; sequencing revealed enriched mutations, in particular in the HC regions. The best 
mutant APE925 was characterized having a KD of 25 pM [14]. 
Yeast display has been used frequently for the improvement of affinity [19]. It is however not  
often applied in directed enzyme evolution. Integrating yeast display as one of the main elements,  
Chen et al. developed a general method for the evolution of bond-forming enzymes with an improved 
catalytic activity [20]. In this method, an enzyme library is anchored on the yeast cell surface as a 
fusion to the Aga2p cell surface mating factor. The latter is covalently bound to the Aga1p mating 
factor via the S6 peptide which functions as a reactive handle. Bacillus subtilis Sfp phosphopantetheinyl 
transferase enables covalent attachment of substrate 1 to the S6 peptide. Substrate 2, conjugated to an 
affinity tag (e.g., biotin), is added to the substrate 1-conjugated enzyme library displayed on yeast 
cells. Following incubation with substrate 2, cells are stained with a fluorescently labeled molecule 
that can bind to substrate 2’s affinity tag, enabling isolation by FACS (Figure 1). 




Figure 1. An overview of the yeast display system used in the evolution of bond-forming 
enzymes. The enzyme library is displayed on the yeast surface fused to the Aga2p mating 
factor. Aga2p is bound covalently to the Aga1p mating factor. Substrate 1 is linked to the 
system via the reactive handle S6. Substrate 2, which is conjugated to an affinity tag, is 
added to the system. Only active library members will catalyze the reaction between 
substrate 1 and 2. This is followed by the addition of a fluorescent molecule that binds to 
the affinity handle and screening using FACS [20]. 
To validate the system, the transpeptidase sortase A (SrtA) from Staphylococcus aureus was used. 
SrtA recognizes an LPXTG motif (X being any amino acid) and cleaves the scissile amide bond 
between threonine and glycine using a nucleophilic cysteine residue. The resulting acyl-enzyme 
intermediate is resolved with (GGG)n-linked molecules resulting in a fusion peptide or protein [21]. 
Wild type SrtA was randomly mutated using an error prone PCR (epPCR) method and the resulting 
library was displayed on the Saccharomyces cerevisiae strain ICY200. The SrtA substrate GGGYK 
was covalently linked to the S6 peptide, while the second substrate, a biotinylated peptide conjugated 
to an LPETG recognition motif, was added exogenously. Incubation of the enzyme library with the 
substrates was followed by addition of fluorescently labeled streptavidin to detect the biotinylated 
LPETG peptide. In four rounds, the cells were screened with FACS under increasing selection 
pressure; the surviving genes were subjected to DNA shuffling, displayed on yeast cells and sorted 
again four times. After the final round, the extent of product formation was 40-fold higher than that of 
wild type SrtA. One variant with four mutations exhibited a 140-fold increase in LPETG-coupling 
activity (kcat/KM) compared to the wild type, though showing a decreased GGG substrate binding [20]. 
Further engineering of this variant led to the construction of the pentamutant eSrtA which showed a 
120-fold higher kcat/KM for the LPETG substrate and a 20-fold higher KM for the GGG substrate. 
The pentamutant eSrtA from the previous study was used as a starting point in the reprogramming 
of the enzyme’s substrate specificity towards the substrates LAETG or LPESG [22]. eSrtA has a  
103-fold preference for LPETG over LAETG, and a five-fold preference for LPETG over LPESG. The 
eSrtA gene was subjected to chemical mutagenesis, and the library was displayed on the yeast surface, 
together with the LAETG or LPESG substrate. After three rounds of screening and further mutagenesis 
steps, the best variants showed a 51,000-fold change in specificity for LAETG instead of LPETG,  
and a 125-fold change in specificity for LPESG instead of LPETG. Importantly, there was no loss in 
catalytic efficiency compared to eSrtA [22]. 
Yeast endoplasmic reticulum sequestration screening (YESS) was developed as a general, highly 
versatile eukaryotic system for directed evolution of proteolytic substrate selectivity and activity [23,24]. 
YESS is based on the co-expression of a tobacco etch virus protease (TEVp) mutant library as a fusion 
with multifunctional sequences. These include sequences encoding yeast adhesion receptor subunit 
Aga2, selection and counterselection substrates flanked by epitope tags, and an ER retention signal. 
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Once the ER retention sequence and respective epitope tags are cleaved off by the protease, what 
remains of the (counter-) selection substrate will migrate to the S. cerevisiae cell surface; there, it will 
be anchored to the cell wall via Aga2, and the epitope tags can be detected by fluorescently labeled 
anti-epitope antibodies (Figure 2). The availability of these epitope tags depends on which substrate is 
cleaved. Multicolor FACS can be used to sort cells exhibiting a characteristic fluorescence profile 
corresponding to the selective proteolysis only at the desired substrate sequence. As a consequence, 
rare cells expressing a protease variant capable of specifically cleaving at only the desired new 
sequence are enriched. Using a counterselection substrate is key to avoiding isolating mutants with 
relaxed specificity. 
 
Figure 2. Schematic overview of the yeast endoplasmic reticulum sequestration screening 
(YESS) system. Both protease and substrate contain a C-terminal endoplasmic reticulum 
(ER) retention sequence. Within the ER, the protease can move in close proximity to the 
substrate. Depending on the specificity of the engineered protease, proteolysis of the 
selection substrate or counterselection sequence takes place. This results in the removal of 
the ER retention sequence and respective epitope tags located on the substrate fusion 
polypeptide. The remaining N-terminal portion of the polypeptide is then displayed on the 
yeast cell surface. Each cell is labeled with fluorescently conjugated anti-epitope tag 
antibodies and screened using multicolor FACS [24]. 
Yi et al. validated YESS by altering the substrate specificity of TEVp using the S. cerevisiae strain 
EBY100 (URA+/leu−/trp−). The protease recognizes the amino acid sequence ENLYFQS/G [25] and 
will cleave between the glutamine (P1) and serine or glycine residues. The substrate sequence was 
randomized at position P1 (ENLYFQS→ENLYFXS, X being any amino acid) to create a substrate 
library. The natural substrate peptide ENLYFQS was used for counterselection. Four residues at the 
TEVp S1 pocket were subjected to saturation mutagenesis as well. In three consecutive rounds,  
Int. J. Mol. Sci. 2015, 16 24923 
 
 
3.3 × 107 mutants were screened. Sequencing of 50 selected clones identified 35 different mutant  
TEVp-substrate combinations, with TEVp variants selectively recognizing six different amino acids at 
position P1. Variants PE3 and PH7, preferring a glutamate and a histidine, respectively, at position P1, 
were selected for further evolution of the catalytic activity. Five rounds of FACS sorting resulted in  
the identification of 17 clones with increased catalytic activity, with two clones, TEV-PE10 and  
TEV-PH21, showing the highest activity. TEV-PE10 showed a 13-fold higher kcat/KM value for its 
preferred ENLYFES substrate compared to the wild type substrate, resulting in 5000-fold reversal of 
substrate specificity. Similarly, TEV-PH21 showed a seven-fold higher kcat/KM for the ENLYFHS 
substrate compared to the wild type substrate; this corresponds to an 1100-fold reversal of substrate 
specificity compared to the wild type TEVp. 
To demonstrate the generality of the YESS system for the directed evolution of proteases, 
analogous constructs were created for hepatitis C virus protease (HCV-P) and human granzyme K 
(GrK) in conjunction with their preferred substrate sequences. Yeast cells displaying these constructs 
showed a relatively similar fluorescence readout compared to controls lacking proteases. In addition, 
Yi et al. showed that the YESS system could also be used for the detection of tyrosine phosphorylation 
by human Abelson tyrosine kinase (AblTK). Promising results from these experiments indicate that the 
YESS system could have a broader applicability in directed evolution [24]. 
2.2. Prokaryotic Cytoplasmic Screening of Protein Variants 
Kostallas and Samuelson used bacterial cells to develop a cytoplasmic screening platform for the  
in vivo activity and solubility of proteases, as not all enzymes can be expressed in yeast cells. In their 
proof-of-principle enrichment experiments, TEVp was used [26]. In this method, E. coli DH5α cells 
are used for the constitutive expression of green fluorescent protein (GFP) fused to ssrANY, and  
co-expression of TEVp variants. ssrANY, an optimized variant of ssrA [27], functions as a degradation 
tag which is recognized by the cytoplasmic protease ClpXP, resulting in degradation of GFP and 
elimination of fluorescence [28,29]. Introduction of a protease cleavage site between the GFP and the 
ssrANY genes enables selection of a substrate-specific protease: the ssrANY-tag will be removed and, 
therefore, GFP will be salvaged from degradation. The resulting fluorescence intensity correlates with 
protease activity and permits cell sorting with FACS [24]. Using this system, differences in the substrate 
processing efficiency of the wild type TEVp were analyzed. Two fusion proteins, GFP-subG-ssrANY 
containing the natural TEVp cleavage site ENLYFQG and GFP-subP-ssrANY with the non-canonical 
ENLYFQP sequence were used. In a proof-of-principle experiment, cells co-expressing TEVp and 
GFP-subG-ssrANY were mixed with cells co-expressing TEVp and GFP-subP-ssrANY in a ratio of 
1:100,000. The mixture was sorted in two rounds of FACS; 71% of the most fluorescent population 
appeared to express the wild type substrate GFP-subG-ssrANY. This is translated into a 69,000-fold 
enrichment of cells expressing the GFP-subG-ssrANY fusion compared to the starting point [26]. 
To assess TEVp’s substrate specificity, three combinatorial substrate libraries with sequences 
XNLXFXG, XNLXFXX and EXXYXQX (X being any amino acid) were constructed and 
constitutively expressed in E. coli DH5α. The libraries were co-expressed with TEVp and fluorescent 
clones were collected. After two rounds of sorting, more than 78% of the clones from all libraries 
showed high fluorescence intensity. Sequencing results showed that the selected peptide substrates had 
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sequences identical to or having high sequence similarity with the wild type substrate ENLYFQGS. 
Furthermore, no clones expressed a better proteolytic substrate in terms of kcat/KM than the wild type 
substrate ENLYFQGS. Though this method corroborates TEVp’s wild type substrate sequence, it 
cannot confirm the site at which cleavage actually takes place. This could be a limiting factor for 
proteases of which the substrate profile is not as well studied as for TEVp [30]. 
The previously mentioned FACS-based screening platforms are based on a fluorescence signal 
proportional to a specific activity or affinity. Recently, a novel FACS-based screening system for  
the detection of subtle differences in intracellular metabolite concentrations was described. This 
ligand-mediated eGFP-expression system (LiMEx) establishes a competitive relationship between the 
regulation of a fluorescent protein by an effector molecule and the biochemical depletion of this 
effector molecule by a co-expressed recombinant enzyme [31]. The fluorescence intensity originating 
from the fluorescent protein can thus be used to quantify the enzymatic activity. Cheng et al. used the 
regulation of arginine biosynthesis in E. coli to validate the LiMEx system. This amino acid is 
synthesized from citrulline by employing argininosuccinate synthetase (ASS) and argininosuccinate 
lyase (ASL) [32]. ASS is encoded by argG, the transcription of which is regulated by the arginine 
repressor (ArgR). As eGFP is under the control of the argG promoter, tight binding of ArgR in the 
presence of co-repressor arginine to the argG promoter region suppresses eGFP expression. Thus, the 
intracellular arginine concentration, even in the micromolar range, can be correlated to eGFP 
fluorescence under physiological conditions (Figure 3). 
 
Figure 3. Scheme showing the ligand-mediated eGFP-expression system (LiMEx). 
Regulation of a fluorescent protein is dependent on the competitive relationship between 
the effector molecule and the enzymatic performance of a co-expressed recombinant 
enzyme. Upon high enzymatic activity, the effector is depleted (indicated with a black 
cross), which results in expression of the fluorescent protein. In contrast, an enzyme 
variant with low activity is unable to bind the effector molecule, which is subsequently 
intercepted by the repressor. Together with the effector molecule, the repressor binds 
tightly to the promoter region of the fluorescent protein and suppresses the expression of 
the protein (indicated with a red cross). The signal derived from the fluorescent probe is 
screened using flow cytometry [31]. 
The arginine concentration can be varied by the activity of a co-expressed arginine-metabolizing 
enzyme. To this purpose, Pseudomonas plecoglossicida arginine deiminase (PpADI) was co-expressed 
Int. J. Mol. Sci. 2015, 16 24925 
 
 
in E. coli; expression of the enzyme will lead to a decrease in the intracellular arginine concentration 
and a correlated increase in eGFP fluorescence. The previously evolved PpADI mutant M21 was used 
as a template for randomization by epPCR. After three rounds of directed evolution, PpADI activity 
was detected in 90% of the sorted clones, with 30% of that population showing at least a 1.5-fold 
improvement compared to the parent M21. The best variant, M31, showed a 2.8-fold increase in 
kcat/KM compared to the parent M21, which corresponded to a 970-fold increase in catalytic efficiency 
compared to the wild type PpADI [31]. 
3. Man-Made Compartments in FACS Screening Platforms 
As described above, maintaining a link between genotype and phenotype is naturally ensured by 
compartmentalization of the library in whole cells. Nevertheless, the use of cells significantly reduces 
the size of libraries that can be sampled due to the need of transformations or transfections. 
Furthermore, as cell viability must be maintained, the scope of buffers, solvents and temperatures that 
can be used are limited [33]. In the last two decades, the field of cell-free directed evolution has 
rapidly grown and expanded with the emergence of in vitro compartmentalization techniques. 
3.1. Emulsion-Based Compartments 
The first compartments were water-in-oil droplets, formed by mixing water with a mineral oil 
containing an adjuvant surfactant [8]. However, as these droplets are not compatible with FACS-based 
screening, it is necessary to cover the continuous oil phase with an external aqueous phase. The 
resulting water-in-oil-in-water compartments or double emulsions are compatible with flow cytometry, 
thus broadening the applicability of emulsion-based compartments [34]. 
Ostafe et al. developed an assay for the detection of cellulase-based decomposition into soluble 
sugars. The so-called ViPer assay (Figure 4A) is based on the indirect measurement of the reduction of 
sugars [12,35]. Cellulases convert cellulosic substrates into glucose monomers or polymers. These in 
turn are converted by hexose oxidase to produce hydrogen peroxide; the latter is used by vanadium 
bromoperoxidase (VBrPOx) in the conversion of aminophenyl fluorescein (APF) into fluorescein.  
The accumulation of fluorescein is thus a measure of the cellulase activity and can be used to sort  
cells [12]. Only the cellulases are expressed in S. cerevisiae; the cells are in vitro compartmentalized 
together with all other necessary enzymes and substrates. 
In proof-of-principle experiments, this assay was used to enrich S. cerevisiae YPH500 cells 
expressing Cel5A cellulase from a mixture of 5% cellulase-positive cells and 95% cellulase-negative  
S. cerevisiae YPH500 cells transformed with the empty vector. The cells were emulsified together  
with all other components required for the assay in double emulsions. After one round of selection,  
cells expressing Cel5A showed accumulation of fluorescein in the droplets and could be sorted 
resulting in a 12-fold enrichment of positive cells. Although this system has only been validated in 
proof-of-principle experiments, it could be used to sort cellulase libraries in search of more active 
variants [12]. 
The so-called ProFC-IVC technique (Figure 4A) was developed as a screening system to evolve 
proteases with increased resistance to inhibitors [36]. Here, Bacillus subtilis WB800N cells are 
compartmentalized in water-in-oil-in-water droplets. As this strain is deficient in extracellular 
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proteases, cells will only express and secrete the protease of interest while background signals are kept 
to a minimum [36]. Both cells and substrate, a rhodamine 110-containing peptide, are entrapped in a 
double emulsion in the presence of the inhibitor antipain dihydrochloride [36]. The secreted protease 
of interest then converts a soluble substrate into a fluorescent product; thus, the protease activity is 
correlated with the fluorescence intensity. 
As proof of principle, the model protease subtilisin Carlsberg (SC) was subjected to epPCR. Cells 
expressing SC variants were encapsulated with the inhibitor antipain dihydrochloride and the peptide 
substrate bis(suc-AAPF)-rhodamine110; due to the negative charge of the succinyl group, the substrate 
was retained within the emulsion droplets. The library, containing ~105 variants, was screened in three 
rounds of FACS to identify variants with increased resistance towards the antipain dihydrochloride 
inhibitor. After the final round, the library could be enriched approximately 12-fold compared to the 
unsorted library. A small fraction of the sorted cells was analyzed for their protease activity. One clone 
exhibited a 160% increase in residual activity in the presence of the inhibitor compared to the wild 
type, despite a reduced absolute activity [36]. This system can likely be modified to select for other 
properties (e.g., thermostability, altered pH profile or ionic strength resistance) or to evolve other proteases. 
 
Figure 4. Schemes showing the emulsion-based compartments. Scheme (A) gives a 
general overview of the ViPer [12,35] and the ProFC-IVC [36] methods. Enzyme-secreting 
cells are encapsulated together with the substrate into double emulsions. The reaction 
between the secreted enzyme and the substrate results in the formation of a fluorescent 
product. The signal is measured using flow cytometry; Scheme (B) represents a novel 
liposome display system [37]. In this cell-free translation system, DNA encoding a 
membrane protein of interest is encapsulated in a cell-sized phospholipid vesicle together 
with a HaloTag protein. After the membrane protein’s expression and formation of pores, 
small molecules—ligands conjugated to a fluorophore—are able to enter the liposome and 
react with the HaloTag protein. The transporter activity of the membrane protein is 
correlated with the fluorescence signal, which is measured using flow cytometry. 
To extend compartmentalization techniques to the directed evolution of membrane proteins,  
Fujii et al. developed a novel liposome display system (Figure 4B) [37]. Liposome display enables 
evolution of membrane proteins based on their transporter activity. In a cell-free translation system, 
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DNA encoding the membrane protein of interest and a HaloTag protein are mixed. The mixture is 
encapsulated in liposomes in such a way that each liposome contains a single DNA molecule. The 
membrane protein is expressed in vitro in the lipid bilayer of cell-sized, unilamellar liposome [38,39]. 
Proof of concept experiments were carried out using the pore-forming α-hemolysin (AH) from  
S. aureus. The AH gene was randomly mutated by epPCR and variants were selected for improved  
pore-forming activity. Within the liposome, AH was expressed as monomers in the aqueous phase. The 
water-soluble monomers spontaneously integrated into the lipid bilayer, where they associated into 
heptamers. Consequently, pores were formed, which enabled molecules with a molecular weight 
smaller than 3 kDa to enter the liposome [40]. For the detection of the pore-forming activity of  
α-hemolysin, a HaloTag ligand conjugated to AlexaFluor 488 (AF488) was added to the outer solution. 
The ligand could only cross the lipid bilayer via the AH-formed nanopores; in the liposome, the ligand 
covalently bound to the HaloTagged protein. Accumulation of AF488 fluorescence was therefore 
indicative of a greater number of pores formed and thus a higher AH activity. The top 1% population 
showing the highest fluorescence was sorted; after 20 rounds of selection, a mutant was identified that 
showed a 30-fold higher pore-forming activity compared to the wild type. 
This method can potentially be applied to a variety of membrane proteins that have been integrated 
successfully into lipid-bilayer membranes (e.g., Fo-a subunit of F1Fo-ATP synthase [41], (1,3)-β-D-glucan 
(curdlan) synthase (CrdS) [42] or a multidrug transporter (emrE) [43]). Furthermore, liposome display 
is compatible with multimeric proteins, thus enabling the selection of homo- and heterooligomeric 
proteins [37]. 
3.2. Polymer-Based Platforms 
Artificial compartments can also be created using polymers. Polymer-based compartments are 
highly permeable and biocompatible. They are built from scratch in a stepwise manner either by means 
of a polyelectrolyte multilayer assembly [44] or a “self-encapsulation” radical reaction process [45] 
(Figure 5). In the first system, the polyelectrolyte multilayer technology takes advantage of  
opposing electrostatic charges of the polymers (e.g., anionic alginate, cationic chitosan). When this 
layer-by-layer (LbL) assembly process is finished, the innermost layer—the template of the established 
compartment—is removed. Remaining layers enveloping the hollow structure of the capsule function 
as a multilayer scaffold [44]. This approach has already been successfully used for the encapsulation of 
yeast and bacterial cells [46–48]. In the “self-encapsulation” method, the capsule is produced by means 
of a free radical polymerization of poly(ethylene glycol) acrylate. The polymerization reaction is 
triggered by hydroxyl radicals, products of a Fenton reaction between hydrogen peroxide and Fe2+  
ions [49]. 
The advantage of the polymer-based compartments over water-in-oil emulsions is their high 
stability in aqueous solutions; this allows them to be analysed by standard FACS equipment directly. 
In addition, polyelectrolytes can withstand more extreme conditions than emulsion-based droplets. 
Finally, the semipermeable nature of the polymer-based compartments makes them suitable for 
multistep processes, in which the exchange of different reaction components needs to be adjustable in 
comparison to emulsion-based droplets [48]. 




Figure 5. Principle of polymer-based platforms. (A) The fur shell method relies on the 
coupled reactions of two enzymes in which D-δ-gluconolactone is produced. The latter  
is a substrate in the Fenton reaction, which leads to the production of hydroxyl radicals, 
needed in the co-polymerization of poly(ethylene glycol)-diacrylate (PEG-diacrylate)  
and Polyfluor 570 [45,50]; (B) In cellular high-througput encapsulation solubilization and 
screening (CHESS), the polymers are assembled in a layer-by-layer manner. Each cell is 
subjected to the deposition of alternating layers of oppositely charged polymers [51,52]; 
and (C) Gel-shell beads are produced with the help of a microfluidic device. Water-in-oil 
droplets (indicated with a blue circle), containing agarose and a polyanion, are formed. 
With a decrease in temperature to 4 °C, agarose gelates within the water droplet (indicated 
with a brown circle). To decrease the molecular weight cut-off, the beads are de-emulsified 
in the presence of a polycation. Driven by the opposite charges, the polyanion and 
polycation form a shell bead that encloses any compounds of the reaction [48]. 
The so-called fur-shell screening platform was developed as a generally applicable screening 
system for hydrolase activity [45]. In this method, an enzyme reaction of a glucose oxidase coupled 
with an active hydrolase leads to hydrogel shell formation and co-polymerization of fluorescent 
methacryloxyethyl thiocarbamoyl rhodamine B monomer (Polyfluor 570) around E. coli cells; the 
resulting shell resembles a fur and is fluorescent, which makes this technique compatible with  
FACS [45,50]. 
This method was used to improve the catalytic activity of Yersinia mollaretti phytase (YmPh) 
towards the non-natural substrate 4-methylumbelliferyl phosphate (4-MUP). An epPCR mutant  
library of YmPh was expressed in E. coli BL21(DE3) LacIQ1 cells. YmPh-catalyzed hydrolysis of 
glucose-6-phosphate led to the formation of β-D-glucose, which was oxidized by glucose oxidase 
oxidized to δ-gluconolactone under formation of hydrogen peroxide. Via the Fenton reaction,  
co-polymerization of the PEG-acrylate monomer with fluorescent Polyfluor 570 was triggered, thus 
forming a PEG-Polyfluor 570 hydrogel shell. As only cells containing active YmPh variants showed 
hydrogel formation and therefore fluorescence, a cell mixture containing 40% active variants could be 
enriched to 89% active variants in a single round of screening [45,50]. For further characterization, the 
10% YmPh variants showing the highest fluorescence were collected and their activity was determined 
using a microtiter-based activity assay using 4-MUP. An increased activity was detected for 11 YmPh 
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variants, of which the best variant showed a 31% increase in kcat towards 4-MUP compared to the wild 
type. In addition, this mutant also showed a 5% increase in kcat for the natural substrate phytic acid in 
comparison with wild type YmPh [45]. 
Recently, Lülsdorf et al. showed that the fur-shell technology is also applicable to other hydrolases. 
They used Bacillus licheniformis p-nitrobenzyl esterase (pNBEBL), Bacillus subtilis lipase A (BSLA) 
and a cellulase from a metagenome library (CelA2). pNBEBL and BSLA hydrolyzed β-D-(+)-glucose 
pentaacetate, whereas CelA2 converted the β-D-cellobioside 4-MUC. After a single round of directed 
evolution, the kcat of the best pNBEBL mutant towards β-D-(+)-glucose pentaacetate was increased  
seven-fold compared to the wild type. A BSLA variant was identified showing a 1.3-fold increased kcat 
towards the screening substrate p-nitrophenyl acetate (pNPA) compared to the wild type. Finally, the 
catalytic activity of CelA2 was improved as well: the kcat towards the β-D-cellobioside (4-MUC) 
substrate was enhanced by 1.9-fold compared to the wild type [50]. 
Cellular high-throughput encapsulation solubilization and screening (CHESS) was originally 
developed to increase the thermostability and detergent stability of G-protein coupled receptors 
(GPCRs) to facilitate crystallization. Single E. coli DH5α cells expressing the protein of interest are 
encapsulated by layers of the oppositely charged polymers chitosan and alginate [47,51]. The cell 
membrane is solubilized leaving only the capsule as a semipermeable barrier between cell components 
and the environment. The main advantage of the barrier is that small molecules such as fluorescent 
substrates and ligands can diffuse into the capsules whereas large proteins and the genetic information 
are retained: the molecular weight cut-off is 70 kDa. Therefore, a protein of interest smaller than  
70 kDa needs to be expressed as a fusion protein, e.g., partnering with GFP or MBP molecules. 
Importantly, CHESS capsules are only stable in the range of pH 6–9: below pH 6 the capsules will 
aggregate, above pH 9 the capsules will dissolve [52]. 
CHESS was first applied to the rat neurotensin receptor (NTS1); the randomized mutant library 
StEPM303 [53] expressed in E. coli DH5α cells was encapsulated with alginate and chitosan, and 
subjected to a mixture of detergents. Next, the capsules were incubated with the fluorescent ligand 
BODIPY-FL-labeled neurotensin 8–13 (FL-NT), after which they were screened for expression of the 
membrane protein using FACS. In each of the three screening rounds, the top 0.5%–1% of the 
fluorescent capsules were collected. Finally, DNA from 20,000 collected capsules was recovered and 
analyzed for the ability of selected variants to bind FL-NT in n-heptyl-β-D-thioglucopyranoside 
(HTG). The best mutant NTS1-H4 showed an increase in thermostability of 21.6 °C for the bound and 
26.8 °C for the apo state compared to the wild-type NTS1 [54]. 
CHESS has also been applied to soluble proteins, shown by optimization of the detergent stability 
and thermostability of superfolder green fluorescent protein (sfGFP). An epPCR library of 1.2 million 
sfGFP mutants fused to MBP was expressed in E. coli DH5α and encapsulated in chitosan and 
alginate. Before FACS screening the capsules were heated at 60 °C. The 1% capsules showing the 
highest fluorescence were collected, and DNA extracted from these capsules was subjected to two 
more rounds of screening with increasing temperatures for each round. Two mutants were identified: 
the very stable GFP (vsGFP) showed an increase in melting temperature of 12.9 °C in 2% (w/v) SDS 
over the wild type, while the ultra-stable GFP (usGFP) exhibited even a 19.3 °C improvement in  
2% (w/v) SDS [52]. 
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The gel-shell bead (GSB) approach also makes use of LbL technology for compartmentalization [48]. 
For the generation of GSBs, single E. coli BL21(DE3) cells expressing the protein of interest are 
compartmentalized in water-in-oil emulsion droplets using a microfluidics droplet generator. One 
aqueous stream contains the cells, liquid agarose and alginate; the aqueous stream is then mixed with  
a cell lysis reagent and a fluorescent substrate for catalysis. The catalytic reaction can be precisely 
controlled and is stopped by heat inactivation of the enzyme followed by cooling to 4 °C to solidify the 
agarose, thus forming a gel bead. Since gel beads have a ~250 kDa cut-off, an additional layer or shell 
is needed to maintain a link between genotype and phenotype. The additional shell around the gel 
beads reduces the molecular weight cut-off to ≤2 kDa and therefore guarantees the retention of DNA, 
protein and fluorescent product within the gel-shell beads. After sorting by FACS, genes of improved 
variants can be recovered by increasing the pH to 12 to disrupt the beads [48]. GSBs can also be 
recovered after use, offering the advantages of immobilized enzymes, though without having to 
express, purify and immobilize the enzymes. In comparison to the CHESS capsules described 
previously, GSBs are not only stable at high temperatures (up to 95 °C) and in the presence of organic 
solvents, but at pH values between 2 and 11 as well. However, microfluidic devices are needed for the 
generation of GSBs whereas CHESS capsules can easily be formed using standard laboratory equipment. 
GSBs were first applied in the improvement of a phosphotriesterase (PTE) from Pseudomonas diminuta 
towards its native substrate, the pesticide paraoxon. Fischlechner et al. created an epPCR library of  
5 × 105 clones. After a single round of screening followed by an analysis in a 96-well plate for the 
turnover of the pesticide paraoxon, the best mutant PTEF9 was selected: it exhibited an eight-fold 
improved kcat/KM for the pesticide paraoxon compared to the parent PTER8 [48]. 
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Table 1. FACS-based screening platforms described in this review. 
Protein Experiment Compartment Result 
Throughput 
(Events/s) 
Nature’s own compartments 
Antibodies (IgG) [14] 
Selection and  
affinity maturation  
Whole cells,  
mammalian display 
Improvement in binding affinity towards human cytokine 
(hβNGF) ND 
Staphylococcus aureus 
sortase A (SrtA) [20] 
Mutagenesis  
(epPCR, DNA shuffling 
and saturation mutagenesis) 
Whole cells,  
yeast display 
140-fold improvement in LPETG-coupling activity ND 
S. aureus SrtA mutant 
(eSrtA [20]) [22] 
Mutagenesis  
(epPCR, DNA shuffling 
and saturation mutagenesis) 
Whole cells,  
yeast display 
51,000-fold change in specificity for LAETG instead of 
LPETG and a 125-fold change in specificity for LPESG 
instead of LPETG 
ND 
Tobacco Etch Virus 
protease (TEVp) [24] 
Mutagenesis via epPCR 
Whole cells,  
yeast display 
1100–5000-fold reversed substrate specificity 
~2 × 108 
cells 
screened 
TEVp [26] Enrichment 
Whole cells,  
intracellular expression 
69,000-fold enrichment for variants recognizing the  
natural substrate 
300 
TEVp [30] Site-directed mutagenesis 
Whole cells,  
intracellular expression 
Substrate profiling 300 
Pseudomonas 
plecoglossicida arginine 
deiminase (PpADI) [31] 
Mutagenesis (epPCR) 
Whole cells,  
intracellular expression 
2.8-fold increase in kcat/KM in comparison to the parent 
PpADI mutant M21 
5000 
Man-made compartments (emulsion-based) 
Cellulase Cel5A [12] Enrichment 
Whole cells,  
double emulsion droplets 
12-fold enrichment of active variants form a mixture 
containing 5% cells expressing cellulase 
8000 to 
20,000 
Subtilisin Carlsberg  
(SC) [36] 
Mutagenesis (epPCR) 
Whole cells,  
double emulsion droplets 
160% increase in resistance towards antipain dihydrochloride 8000 
α-Hemolysin [37] Mutagenesis (epPCR) Cell-free,  
liposome display 
30-fold higher pore-forming activity ND 
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Table 1. Cont. 
Protein Experiment Compartment Result 
Throughput 
(Events/s) 
Man-made compartments (polymer-based) 
Yersinia mollaretii phytase 
(YmPh) [45] 
Mutagenesis (epPCR) Whole cells, fur-shell 




(Bacillus licheniformis);  
lipase A (Bacillus subtilis);  
cellulase (CelA2) 
(metagenome library [55]) [50] 
Mutagenesis (epPCR) Whole cells, fur-shell 
7-fold increase in kcat towards pNPA; 1.3-fold increase in kcat 
towards β-D-(+)-glucose pentaacetate; 1.9-fold increase in kcat 
towards 4-methylumbelliferyl-β-D-cellobioside, respectively 
5000 
G-protein coupled receptors 
(GPCRs) [54] 
Mutagenesis (StEP, 
Slonomics® technology [53], 
Martinsried, Germany) 
Whole cells, CHESS ~26.8 °C increase in thermostability of NTS1 8000 
sfGFP [52] Mutagensis (epPCR) Whole cells, CHESS ~19 °C increase in thermostability in 2% (w/v) SDS 8000 
Pseudomonas diminuta 
phosphotriesterase [48] 
Mutagenesis (epPCR) Cell lysate, GSBs 
19-fold increase in kcat/KM towards  
tetraethyl-O-fluorescein diphosphate 
~2800 
ND indicates the throughput has not been determined or stated; epPCR, error-prone polymerase chain reaction; CHESS, cellular high-throughput encapsulation 
solubilization and screening; GSB, gel-shell beads. 
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4. Microfluidics Screening Platforms 
Despite a significant extension of the versatility of conventional FACS by application of different 
compartmentalization systems, FACS-based screening platforms still face some limitations. The main 
problem is that the compartments cannot be formed and manipulated (e.g., droplet fusion, fission, or 
mixing) within the experiment in a controlled manner [56]. This leads to the formation of highly 
polydisperse compartments or to polymer aggregation. Consequently, compartments of different sizes 
carrying proteins with the same activity can lead to incomparable assay outcomes [57,58]. In addition, 
bulk emulsion droplets are hard to manipulate: it is very difficult and sometimes even impossible to 
add new reagents to pre-formed droplets at defined times [9,59]. 
To overcome the limitations mentioned above and to increase the throughput of screening 
platforms, new, faster and more economical approaches are being investigated. Microfluidics enable 
droplet manipulation, incubation and sorting all in one system [60]. Different droplet-based 
microfluidic modules have been developed, which can control the formation of highly monodisperse 
single [61] and double emulsions [62] (Figure 6). Other modules can measure reaction kinetics in 
microfluidic systems [63] and sort droplets [64] (Figure 7). Additionally, methods for the delivery of 
fluorogenic substrates into the droplets have emerged; adding a substrate into the stream carrying an 
enzyme is usually done prior to microdroplet formation [65,66]. Fluorogenic substrates can also be 
injected or fused with a pre-formed droplet at a defined time, depending on the kinetics of the enzymatic 
reaction. This enables adjustment of the reaction’s incubation time prior to selection [59,67,68]. 
 
Figure 6. Representation of a droplet generator module of a microfluidic screening 
platform. Aqueous stream 1 contains the fluorogenic substrate which can be supplemented 
with lysis reagents. The stream is combined with aqueous stream 2, which carries a 
suspension of cells displaying, expressing or secreting the protein of interest and variants 
thereof, or a PCR mixture (in vitro systems). The water-in-oil droplets are formed at a 
flow-focusing junction and move into an incubation line. Droplets carrying active  
variants are shown in green. The incubation line is either directly connected to the next 
module of the platform (sorting module, Figure 6) or it is intersected with an additional 
module—the droplet fusion device (not depicted)—which enables modification of 
preformed droplets [59,64,65,68–70]. 




Figure 7. Representation of a droplet sorting module of a microfluidic screening platform. 
The module consists of a sorting junction controlled by a fluorescence detector and electric 
field applied across two electrodes. Each of the generated emulsion-based droplets is 
examined with respect to its fluorescence. The presence of fluorescence (green droplets) 
activates the alternating current (AC) electrodes, which results in the formation of the 
electric field. Once droplets come into contact with the electric field, the dielectrophoretic 
activity of the droplets is triggered: they will become polarized. Consequently, the polarized 
droplets can move in two directions at the junction. If the dielectric constant of a droplet is 
higher than the conductivity of the electric current, the droplets will move in the direction 
of the increasing electric field (+). In contrast, if the dielectric constant of a droplet is 
lower, the droplets move away from high field regions (−) [59,64,65,68–70]. 
Nevertheless, microfluidic platforms pose a technical challenge [57]. To build microfluidic devices, 
specialized and non-standard equipment is needed. Therefore, FACS-based screening methodologies 
using standard equipment are still favored. However, commercial microfluidic devices, in particular 
microfluidics-based modules for droplet formation, are becoming more easily available [71]. These 
modules can be used for the formation of single and double emulsions [72], and GSBs [48]. As double 
emulsions and GSBs are compatible with standard cell sorters, a pipeline can be created from the 
creation of capsules using microfluidic devices to the analysis; this will enable high-throughput 
screening of libraries for directed evolution [59,68]. An overview of screening platforms based on 
compartmentalization by microfluidics is given in Table 2. 
The first successful microfluidic-based screening application in directed enzyme evolution was 
designed for the selection of improved catalysis of horseradish peroxidase (HRP) towards Amplex 
Ultrared (AUR) [65]. In this method, an HRP mutant library is displayed on the yeast cell surface. The 
yeast cells enter the first microfluidics module via one stream, where they are combined with a second 
stream carrying the fluorogenic substrate AUR. Upon mixing of these two streams, picoliter-volume 
aqueous drops are formed at a flow-focusing junction in fluorocarbon oil. Next, the drops are pooled in 
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an incubation line, which is connected to the screening module. There, the droplets are dielectrophoretically 
sorted according to the fluorescence signal of the reaction product, which is retained within the droplet. 
Two generations of horseradish peroxidase variants were analyzed. In the first generation, two types 
of libraries were created by epPCR and site-specific mutagenesis, each containing >107 mutants of the 
HRP gene. Four sorting rounds of the first generation of both libraries gave a ~2 times increase in the 
mutants’ catalytic efficiency towards the substrate AUR. The 18 best variants were further randomized 
to create a second generation of the HRP mutants. From a pool of 107 variants, the 5%–10% droplets 
with the highest fluorescence were sorted; the 13 best mutants after five rounds of screening all 
showed a significant improvement in kcat/KM with the best mutant showing a seven-fold increase over 
the wild type HRP. In comparison to robotic microtiter plate screening methods, the microfluidic 
droplet-based approach proved to be 1000-fold faster in the screening of a mutant library [65]. 
Hollfelder and co-workers extended the microfluidics system described above to a bacterial 
cytoplasmic expression system at a picoliter scale [66]. In the first microfluidic device, an aqueous 
suspension of bacterial cells expressing the enzyme of interest is mixed together with a second aqueous 
stream at a flow-focusing junction. The second stream not only carries a substrate for PAS, but is also 
supplemented with cell lysis reagents. After mixing of both streams followed by droplet formation,  
E. coli cells are lysed and protein variants are released into the droplet; during off-chip incubation, 
active enzyme variants convert the substrate into a fluorescent product. Then, droplets are injected  
into the second microfluidic device, where they are sorted dielectrophoretically based on their  
fluorescence signal. 
Directed evolution was applied to increase the promiscuous hydrolytic activity of the arylsulfatase 
from Pseudomonas aeruginosa (PAS) towards the non-native substrate phosphonate. A PAS mutant 
library was expressed in the cytoplasm of E. coli BL21(DE3) cells. After three rounds of sorting in 
which the top 4% brightest droplets were collected, 500 mutants were further analyzed for their 
promiscuous activity. The best mutant showed a six-fold improved hydrolytic activity (kcat/KM) 
towards the non-native substrate phosphonate compared to the wild type PAS. This method proved to 
be a 100 times faster than advanced robotic microtiter plate-based screening systems [66]. 
In another approach proposed by Romero et al. the characterization of a library of enzyme variants 
was done by means of fluorescence-based activity assay followed by deep mutational scanning [71]. In 
this method single E. coli BL21(DE3) cells expressing a library of enzyme variants are combined with 
a substrate and the lysis reagents in the microdroplets using a microfluidic co-flow droplet generator. 
After an off-line incubation, droplets are injected into a microfluidic sorter, where they are analyzed 
based on the level of the fluorescence. Selective electrocoalescence is used to separate 3.4% of positive 
drops that exceeded the threshold of 0.2 fluorescence [73]. Next-generation sequencing data obtained 
from a sorted and an unsorted library are used for the statistical analysis of the frequency of mutations 
that are found in analyzed variants [74]. Deep mutational scanning is a very powerful and promising 
approach that can help to explore the protein fitness landscape by answering fundamental questions on 
the dependence of the protein’s function on mutations [75]. This approach was used to map the activity 
of 10 million epPCR variants of β-glucosidase (Bgl3) from Streptomyces sp. [71]. In this method,  
E. coli BL21(DE3) cells expressing the library were analyzed for their activity towards the substrate 
fluorescein di-(β-D-glucopyranoside). The droplets were collected and incubated off-chip, after which 
the droplets were injected into the microfluidic sorting device where they were screened for 
Int. J. Mol. Sci. 2015, 16 24936 
 
 
fluorescence emission. Prior to sorting, 35% of the library members were found to be functional, 
whereas, after sorting, the fraction of functional variants had increased to 98%. Genes recovered from 
the active droplets were subjected to sequencing analysis to enable high-throughput sequence-function 
mapping. As a result of statistical analyses, a large decrease in the mutation frequency was observed 
for the sorted library when compared with the results obtained for the unsorted library carrying active 
and inactive variants. This suggests that mutations that were not found in the sorted library were 
unfavorable for the proper function of the enzyme. The less tolerant the residue was to mutation, the 
more that position denoted its functional importance. 
Furthermore, to demonstrate the versatility of this platform, the same screening experiment was 
conducted under altered conditions: droplets carrying Bgl3 variants were subjected to a 10-min heat 
challenge at 65 °C to improve the enzyme’s thermostability. After a sorting step, 20% of the initial 
population still showed enzymatic activity. The highest impact on the enzyme’s thermostability 
reached a 5.3 °C higher tolerance [71]. 
The microfluidics platforms described so far make use of bacterial or yeast cells as DNA library 
carriers. Cell-free systems overcome limitations associated with the use of in vivo expression  
systems [76]. A completely in vitro screening system has been developed and its applicability in 
protein engineering experiments has been demonstrated by means of an enrichment experiment for the 
enzyme β-galactosidase [68]. Here, the lacZ gene and lacZmut genes encoding inactive enzyme 
variants were amplified by PCR and mixed into monodisperse droplets. These droplets were fused with 
droplets carrying purified in vitro transcription and translation (IVTT) components, supplemented with 
the fluorogenic substrate fluorescein di-(β-D-galactopyranoside) (FDG). During a 2 h off-chip incubation, 
the lacZ and the lacZmut genes were transcribed and translated, and droplets carrying the active  
β-galactosidase converted the substrate FDG to galactose and fluorescein. After injection into the 
sorting device, the droplets were sorted by fluorescence-activated electrocoalescence (2000 droplets/s), 
allowing for a direct recovery of DNA from the aqueous stream [68]. As a result, lacZ genes encoding 
an active β-galactosidase could be enriched 502-fold from a 1:100 molar ratio mixture of lacZ to 
lacZmut genes. This droplet-based system enabled a reduction of the volume of reagents by ~78,000-fold 
and an increase in sorting speed up to 2000 droplets/s. Consequently, this system turned out to be 
100,000-fold more economical when compared to microtiter plate-based systems. With a still 10-fold 
lower sorting rate, the described microfluidic system compensates for this by being more quantitative 
and flexible than FACS methods based on double emulsions. 
Recently, microfluidic devices were used for the enhancement of production hosts of industrial 
enzymes: a yeast cell library was screened for an improved homologous production of secreted  
α-amylase [69]. Yeast strain MH34 was subjected to irradiation with UV light, thus randomly 
introducing mutations throughout the whole genome. Next, each cell was encapsulated in emulsion 
droplets together with the substrate starch conjugated with the internally quenched BODIPY 
fluorophore. During the 3 h off-chip incubation, the enzyme was produced and secreted into the 
emulsion droplet. While the starch substrate was converted, the BODIPY fluorophores became 
gradually unquenched. The generated emulsion containing converted substrate was injected into a 
separate sorter circuit. Each droplet was screened and sorted based on its fluorescence value. Only the 
droplets that exceeded the threshold value of the top 0.72% most fluorescent population were qualified 
as active and collected. Cells from the sorted population showed on average a 63% higher enzyme 
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production and a 35% higher product yield compared to the unsorted library. Sixty individual clones 
were selected for further characterization. In addition to a higher growth rate, the best clone showed 
twice the α-amylase production of the mother strain. The application of a droplet-based microfluidic 
system instead of a commonly used automated microtiter plate screening system enabled the analysis 
of about 3 × 106 droplets at a rate of 323 droplets/s, an over 300 times higher throughput. This method 
could have a significant industrial value, not only because of the higher rate of library screening but 
also because of the million-fold reduction of reagent consumption [69]. 
The application of a droplet-based microfluidics platform for metagenomic studies was demonstrated 
by the enrichment of cellulolytic microorganisms from environmental samples [77]. Cellulases are a 
mixture of endoglucanases and exoglucanases or cellobiohydrolases working synergistically together; 
they can efficiently hydrolyze cellulosic biomass into fermentable sugars, which are used for the 
production of valuable biofuel. Najah et al. screened a soil sample from a wheat stubble field for 
cellobiohydrolase activity. Bacteria were directly extracted from the soil sample and compartmentalized 
in water-in-oil droplets using a microfluidic drop-maker device. Each droplet contained a fluorogenic 
cellobiohydrolase substrate, β-D-cellobioside-6,8-difluoro-7-hydroxycoumarin-4-methanesulfonate [77]. 
The generated emulsions were incubated off-chip for 24 h at 30 °C. Next, they were injected into  
a fluorescence-activated droplet sorting device. The enzymatic activity in each droplet was assessed by 
the fluorescence obtained from the product of the hydrolysis reaction, sorting the 2% droplets with the 
highest fluorescence. The cellulase activity of the selected bacterial population was also assessed using 
a microtiter plate growth assay containing sodium β-D-cellobioside-6,8-difluoro-7-hydroxycoumarin-
4-methanesulfonate. Both methods enabled the discovery of a diverse population of cellulolytic 
bacteria directly from soil. Nevertheless, the droplet-based method resulted in the selection of a higher 
cellobiohydrolase activity compared to the plate growth assay: this population exhibited a 17-fold 
higher exoglucanase activity as well as a seven-fold endogluconase activity, the latter being important 
in the collective reaction of cellulose hydrolysis. A metagenomics screen revealed a difference in the 
taxonomic diversity obtained after screening: after the microfluidic screening, Paenibacillaceae and 
Paenibacillus species were most abundant, whereas after the microtiter-based method, the Bacillaceae 
species was predominantly found. All in all, the use of the droplet-based microfluidic system enabled 
the screening of 100,000 bacteria in less than 20 min. The use of a state-of-the-art robotic microtiter 
plate screening system would still require more than three days to screen the same number of 
microorganisms. In addition, the reagent volume and costs were ca. 250,000-fold lower for the 
microfluidic system [78,79]. 
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Table 2. Microfluidics-based screening platforms described in this review. 
Protein Experiment Compartment Result 
Throughput 
(Events/s) 
Horse radish peroxidase [65] 
Mutagenesis (epPCR and  
saturation mutagenesis) 
Yeast display,  
drop-based microfluidic system 
7-fold increase in catalytic efficiency 





Cell lysate,  
drop-based microfluidic system 
6-fold increase in promiscuous 
hydrolytic activity towards the 
nonnative substrate phosphonate 
926 
Streptomyces sp.  
β-glucosidase [71] Mutagenesis (epPCR) 
Cell lysate, drop-based microfluidic 
system combined with high-throughput 
DNA sequencing 
5.3 °C increase in thermostability >100 
β-galactosidase [68] Enrichment In vitro transcription and translation, 
drop-based microfluidic system 
502-fold enrichment of positive 
variants from a mixture of active and 
inactive variants 
2000 
Yeast strain MH34α-amylase [69] Mutagenesis (UV irradiation) Whole cells, drop-based  
microfluidic system 
2-fold increase in  
α-amylase production 323 
Cellulases for the hydrolysis of 
cellulosic biomass [79] 
Metagenomics 
Whole cells, drop-based  
microfluidic system 
Identification of microorganisms 
with 17-fold higher  
cellobiohydrolase activity and  
7-fold higher endogluconase activity 
6667 
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5. Future Perspectives 
The continuous evolution of protein engineering strategies is leading to a faster and more specific 
development of valuable (therapeutic) proteins and, in particular, enzymes [80,81]. Apart from 
directed evolution methods used in the techniques described in this review, it is important to mention 
that rational approaches are also increasing in power [82,83]. No matter which method is used or  
how smart the library is, the identification of desirable variants can still be challenging and  
time-consuming. Thus, there is an obvious need for flexible and fast screening methods. A general 
direction observed in the strategies for library screening is the miniaturization of reaction volumes. As 
such, screening technologies are taken to the level of natural compartments—typical bacterial cells 
have volumes of a few femtoliters [9]. 
Microencapsulation approaches combined with FACS analysis have been broadly exploited for 
protein engineering [9]. Nevertheless, only a few enzymes were reported to be routinely engineered 
using the water-in-oil or double emulsion methods [4,9]. One of the main technical difficulties of  
these techniques has been the generation of monodisperse droplets [4]. New technologies based on 
polymerization reactions or the use of microfluidic devices have enabled generation of compartments 
in more controllable way [9,79]. 
Microfluidic systems provide the ability to screen an extensive number of compartmentalized 
reactions in one experimental set-up. They also allow monitoring the actual activity levels of single 
molecules or in single cells. By integrating droplet-maker and manipulation modules with sorting 
devices, it has become possible to perform sophisticated assays for directed evolution. Currently, 
screening platforms are based on the measurement of a fluorescent product. However, other methods 
for optical readouts will become available in the future; some work has already been done on the 
development of microfluidic systems which can use absorbance [84], Raman scattering [85], or 
ultrasound [86] detection as a means to determine enzymatic activity. 
Finally, the drawbacks and advantages of FACS-based and microfluidics-based screening platforms 
are summarized in Table 3. At present, the most versatile as well as user-friendly high-throughput 
screening procedure in protein engineering seems to be a system comprising of both techniques 
combined [57]. The sorting speed of microfluidics-based platforms is still below the capabilities of 
fluorescence-activated cell sorters (FACS) (sorting rates up to 50 kHz; 2000 droplets/s). However, it is 
probably only a matter of time until droplet sorters are able to screen at a higher speed; a new design 
enabling sorting 10 times faster than the fastest available droplet sorter has already been reported. With 
>99% accuracy, it can sort ~108 droplets/h at rates up to 30 kHz, and sorting can still be accelerated. 
Currently, the limiting factor is therefore not the physical mechanism of sorting but rather the 
electronics to detect the droplets [87]. Once these obstacles are removed, these microfluidics-based 
platforms will be of key importance in the directed evolution of enzymes and (therapeutic) proteins. 
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Table 3. Comparison of FACS-based and microfluidics-based screening platforms. 
FACS-Based Microfluidics-Based 
The utility of FACS assays is limited to 
fluorophores that remain inside or  
on the surface of cells 
The utility of microfluidics is broadened to  
components that are secreted 
Water-in-oil emulsions must be converted into a 
water-in-oil-in-water emulsion (double emulsion) 
Water-in-oil emulsions can be sorted directly 
Pre-formed droplets are difficult to manipulate 
(restricted range of assays) 
Pre-formed droplets are easy to manipulate: they can be 
divided, fused, incubated, analyzed, sorted, broken up 
Limited control over the reaction conditions  
in a droplet 
Much greater control over the reaction conditions  
in a droplet 
Lack of control over the droplet volume,  
leading to polydispersity 
Good control over the droplet volume,  
highly monodisperse 
Requires standard cell sorters Requires specialized instrumentation 
Sorting speed up to 20,000 droplets/s Sorting speed up to 2000 droplets/s 
FACS—fluorescence-assisted cell sorting. 
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